Literature DB >> 18243867

Amino-terminal pro-B-type natriuretic peptide: analytic considerations.

Jordi Ordonez-Llanos1, Paul O Collinson, Robert H Christenson.   

Abstract

Amino-terminal pro-B-type natriuretic peptide (NT-proBNP) is a convenient molecule to work with in clinical laboratories, with preanalytic and analytic advantages, such as excellent stability at different temperatures, flexibility in sample type, and strong harmony across all commercially available NT-proBNP assays (including recently released point-of-care methods). Another major advantage of NT-proBNP assays is that they show excellent analytic precision. Reference values for NT-proBNP testing are strongly affected by the population tested. Among nondiseased populations, lower values are expected, whereas in diseased populations, such as in patients with acute dyspnea, higher reference values are more useful. Also, the biologic variability of NT-proBNP should be taken into account to evaluate the significance of any change in its values. When analyzed in patients with stable heart failure, biologic variability was 25%-40%. This article reviews the laboratory aspects of NT-proBNP testing from the perspective of the clinical laboratorian.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18243867     DOI: 10.1016/j.amjcard.2007.11.013

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  22 in total

1.  Common key-signals in learning and neurodegeneration: focus on excito-amino acids, beta-amyloid peptides and alpha-synuclein.

Authors:  L F Agnati; G Leo; S Genedani; L Piron; A Rivera; D Guidolin; K Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2008-11-19       Impact factor: 3.575

2.  Pedal Edema as an Indicator of Early Heart Failure in the Community: Prevalence and Associations With Cardiac Structure/Function and Natriuretic Peptides (MESA [Multiethnic Study of Atherosclerosis]).

Authors:  Joseph Yeboah; Alain Bertoni; Waqas Qureshi; Shivani Aggarwal; Joao A C Lima; Nadine Kawel-Boehm; David A Bluemke; Sanjiv J Shah
Journal:  Circ Heart Fail       Date:  2016-12       Impact factor: 8.790

3.  The standards for reporting diagnostic accuracy studies 2015 update: is there a missing link to the triumvirate?

Authors:  Alan H B Wu; Robert H Christenson
Journal:  Ann Transl Med       Date:  2016-02

4.  N-terminal pro-B-type natriuretic peptide in the circulation of fetuses with cardiac malformations.

Authors:  Waltraut M Merz; Kirsten Kübler; Eike Albers; Birgit Stoffel-Wagner; Ulrich Gembruch
Journal:  Clin Res Cardiol       Date:  2011-09-29       Impact factor: 5.460

5.  Predictive value of depressive symptoms and B-type natriuretic peptide for new-onset heart failure and mortality.

Authors:  Krista C van den Broek; Christopher R Defilippi; Robert H Christenson; Stephen L Seliger; John S Gottdiener; Willem J Kop
Journal:  Am J Cardiol       Date:  2011-03-01       Impact factor: 2.778

Review 6.  What can blood biomarkers tell us about cardiovascular risk in obstructive sleep apnea?

Authors:  Ivan Guerra de Araújo Freitas; Pedro Felipe Carvalhedo de Bruin; Lia Bittencourt; Veralice Meireles Sales de Bruin; Sérgio Tufik
Journal:  Sleep Breath       Date:  2015-02-26       Impact factor: 2.816

7.  Is N-terminal pro-B-type natriuretic peptide ready for 'prime time' in severe pneumonia?

Authors:  Juan Felipe Fernandez; Marcos I Restrepo
Journal:  Respirology       Date:  2013-08       Impact factor: 6.424

8.  Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy.

Authors:  W T Longstreth; Richard A Kronmal; John L P Thompson; Robert H Christenson; Steven R Levine; Rebecca Gross; Robin L Brey; Richard Buchsbaum; Mitchell S V Elkind; David L Tirschwell; Stephen L Seliger; J P Mohr; Christopher R deFilippi
Journal:  Stroke       Date:  2013-01-22       Impact factor: 7.914

Review 9.  Clinical applications of N-terminal pro B-type natriuretic peptide in heart failure and other cardiovascular diseases.

Authors:  Da-Rong Pu; Jun R Chiong; Qi-chang Zhou
Journal:  Heart Fail Rev       Date:  2010-07       Impact factor: 4.214

10.  Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Lori B Daniels; Paul Clopton; Christopher R deFilippi; Otto A Sanchez; Hossein Bahrami; Joao A C Lima; Russell P Tracy; David Siscovick; Alain G Bertoni; Philip Greenland; Mary Cushman; Alan S Maisel; Michael H Criqui
Journal:  Am Heart J       Date:  2015-09-28       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.